Larry Mattheakis's most recent trade in Annexon Inc was a trade of 37,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 11, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Annexon Inc | Larry Mattheakis | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
Annexon Inc | Larry Mattheakis | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
Annexon Inc | Larry Mattheakis | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 4,688 | 17,188 | - | 0 | Common Stock | |
Annexon Inc | Larry Mattheakis | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 4,688 | 17,188 | - | 0 | Common Stock | |
Annexon Inc | Larry Mattheakis | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Annexon Inc | Larry Mattheakis | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 12,500 | 12,500 | - | 0 | Common Stock | |
Annexon Inc | Larry Mattheakis | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 220,000 | 220,000 | - | - | Stock Option (Right to Buy) |